Adaptimmune Therapeutics Plc (ADAPY)
0.0268
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Adaptimmune Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2025 | -0.686 |
| March 31, 2025 | -1.301 |
| December 31, 2024 | 6.263 |
| September 30, 2024 | 0.9313 |
| June 30, 2024 | 0.4918 |
| March 31, 2024 | 0.972 |
| December 31, 2023 | 0.6387 |
| September 30, 2023 | 0.2905 |
| June 30, 2023 | 0.208 |
| March 31, 2023 | 0.2722 |
| December 31, 2022 | 0.2818 |
| September 30, 2022 | 0.1976 |
| June 30, 2022 | 0.1705 |
| March 31, 2022 | 0.1591 |
| December 31, 2021 | 0.1237 |
| September 30, 2021 | 0.1078 |
| June 30, 2021 | 0.0815 |
| March 31, 2021 | 0.0736 |
| December 31, 2020 | 0.0695 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.063 |
| June 30, 2020 | 0.0572 |
| March 31, 2020 | 0.1313 |
| December 31, 2019 | 0.2059 |
| September 30, 2019 | 0.1688 |
| June 30, 2019 | 0.1391 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 130.63M |
| Total Liabilities (Quarterly) | 201.59M |
| Shareholders Equity (Quarterly) | -70.96M |